ENCODE cell lines, expression (Ernst 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
FOXK1
|
ENSG00000164916.9 | FOXK1 |
FOXP2
|
ENSG00000128573.18 | FOXP2 |
FOXB1
|
ENSG00000171956.5 | FOXB1 |
FOXP3
|
ENSG00000049768.10 | FOXP3 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
FOXP3 | hg19_v2_chrX_-_49121165_49121288 | -0.49 | 5.1e-02 | Click! |
FOXK1 | hg19_v2_chr7_+_4721885_4721945 | 0.39 | 1.3e-01 | Click! |
FOXB1 | hg19_v2_chr15_+_60296421_60296464 | -0.38 | 1.5e-01 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr7_+_134551583 | 8.78 |
ENST00000435928.1 |
CALD1 |
caldesmon 1 |
chr10_-_101841588 | 8.56 |
ENST00000370418.3 |
CPN1 |
carboxypeptidase N, polypeptide 1 |
chr5_-_42811986 | 7.86 |
ENST00000511224.1 ENST00000507920.1 ENST00000510965.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chr5_-_42812143 | 7.70 |
ENST00000514985.1 |
SEPP1 |
selenoprotein P, plasma, 1 |
chr12_-_9268707 | 7.34 |
ENST00000318602.7 |
A2M |
alpha-2-macroglobulin |
chr1_-_161193349 | 6.71 |
ENST00000469730.2 ENST00000463273.1 ENST00000464492.1 ENST00000367990.3 ENST00000470459.2 ENST00000468465.1 ENST00000463812.1 |
APOA2 |
apolipoprotein A-II |
chr17_-_64225508 | 6.37 |
ENST00000205948.6 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr10_-_52645379 | 6.07 |
ENST00000395489.2 |
A1CF |
APOBEC1 complementation factor |
chr7_+_134464414 | 5.90 |
ENST00000361901.2 |
CALD1 |
caldesmon 1 |
chr10_-_52645416 | 5.83 |
ENST00000374001.2 ENST00000373997.3 ENST00000373995.3 ENST00000282641.2 ENST00000395495.1 ENST00000414883.1 |
A1CF |
APOBEC1 complementation factor |
chr17_+_72426891 | 5.53 |
ENST00000392627.1 |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
chr2_-_188419078 | 5.45 |
ENST00000437725.1 ENST00000409676.1 ENST00000339091.4 ENST00000420747.1 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr10_+_123923105 | 5.33 |
ENST00000368999.1 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr2_-_188419200 | 5.10 |
ENST00000233156.3 ENST00000426055.1 ENST00000453013.1 ENST00000417013.1 |
TFPI |
tissue factor pathway inhibitor (lipoprotein-associated coagulation inhibitor) |
chr17_-_7018128 | 4.61 |
ENST00000380952.2 ENST00000254850.7 |
ASGR2 |
asialoglycoprotein receptor 2 |
chr17_-_7017968 | 4.60 |
ENST00000355035.5 |
ASGR2 |
asialoglycoprotein receptor 2 |
chr17_-_64216748 | 4.49 |
ENST00000585162.1 |
APOH |
apolipoprotein H (beta-2-glycoprotein I) |
chr7_+_134464376 | 4.48 |
ENST00000454108.1 ENST00000361675.2 |
CALD1 |
caldesmon 1 |
chr7_+_134576317 | 4.40 |
ENST00000424922.1 ENST00000495522.1 |
CALD1 |
caldesmon 1 |
chr11_-_115375107 | 4.32 |
ENST00000545380.1 ENST00000452722.3 ENST00000537058.1 ENST00000536727.1 ENST00000542447.2 ENST00000331581.6 |
CADM1 |
cell adhesion molecule 1 |
chr10_+_123922941 | 4.25 |
ENST00000360561.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr10_+_123923205 | 3.98 |
ENST00000369004.3 ENST00000260733.3 |
TACC2 |
transforming, acidic coiled-coil containing protein 2 |
chr7_-_87342564 | 3.75 |
ENST00000265724.3 ENST00000416177.1 |
ABCB1 |
ATP-binding cassette, sub-family B (MDR/TAP), member 1 |
chr17_+_72427477 | 3.56 |
ENST00000342648.5 ENST00000481232.1 |
GPRC5C |
G protein-coupled receptor, family C, group 5, member C |
chr10_+_114710211 | 3.56 |
ENST00000349937.2 ENST00000369397.4 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr2_-_165424973 | 3.48 |
ENST00000543549.1 |
GRB14 |
growth factor receptor-bound protein 14 |
chr3_-_114477787 | 3.31 |
ENST00000464560.1 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr12_-_71551652 | 3.31 |
ENST00000546561.1 |
TSPAN8 |
tetraspanin 8 |
chr11_+_844406 | 3.26 |
ENST00000397404.1 |
TSPAN4 |
tetraspanin 4 |
chr17_-_7082668 | 3.22 |
ENST00000573083.1 ENST00000574388.1 |
ASGR1 |
asialoglycoprotein receptor 1 |
chr10_+_7745303 | 3.21 |
ENST00000429820.1 ENST00000379587.4 |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
chr14_+_21156915 | 3.20 |
ENST00000397990.4 ENST00000555597.1 |
ANG RNASE4 |
angiogenin, ribonuclease, RNase A family, 5 ribonuclease, RNase A family, 4 |
chr1_-_27240455 | 3.19 |
ENST00000254227.3 |
NR0B2 |
nuclear receptor subfamily 0, group B, member 2 |
chr4_+_74269956 | 3.15 |
ENST00000295897.4 ENST00000415165.2 ENST00000503124.1 ENST00000509063.1 ENST00000401494.3 |
ALB |
albumin |
chr11_+_101983176 | 3.12 |
ENST00000524575.1 |
YAP1 |
Yes-associated protein 1 |
chr4_-_186456652 | 3.09 |
ENST00000284767.5 ENST00000284770.5 |
PDLIM3 |
PDZ and LIM domain 3 |
chr7_+_134430212 | 3.00 |
ENST00000436461.2 |
CALD1 |
caldesmon 1 |
chr10_+_114710425 | 2.99 |
ENST00000352065.5 ENST00000369395.1 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr5_-_16742330 | 2.94 |
ENST00000505695.1 ENST00000427430.2 |
MYO10 |
myosin X |
chr10_+_114709999 | 2.87 |
ENST00000355995.4 ENST00000545257.1 ENST00000543371.1 ENST00000536810.1 ENST00000355717.4 ENST00000538897.1 ENST00000534894.1 |
TCF7L2 |
transcription factor 7-like 2 (T-cell specific, HMG-box) |
chr12_-_91574142 | 2.80 |
ENST00000547937.1 |
DCN |
decorin |
chr1_+_207277590 | 2.77 |
ENST00000367070.3 |
C4BPA |
complement component 4 binding protein, alpha |
chr18_-_25616519 | 2.76 |
ENST00000399380.3 |
CDH2 |
cadherin 2, type 1, N-cadherin (neuronal) |
chr14_-_25479811 | 2.74 |
ENST00000550887.1 |
STXBP6 |
syntaxin binding protein 6 (amisyn) |
chr4_-_110723134 | 2.74 |
ENST00000510800.1 ENST00000512148.1 |
CFI |
complement factor I |
chr3_-_114477962 | 2.73 |
ENST00000471418.1 |
ZBTB20 |
zinc finger and BTB domain containing 20 |
chr9_+_124048864 | 2.72 |
ENST00000545652.1 |
GSN |
gelsolin |
chr12_+_13349650 | 2.65 |
ENST00000256951.5 ENST00000431267.2 ENST00000542474.1 ENST00000544053.1 |
EMP1 |
epithelial membrane protein 1 |
chr4_-_186456766 | 2.62 |
ENST00000284771.6 |
PDLIM3 |
PDZ and LIM domain 3 |
chr12_+_100867486 | 2.60 |
ENST00000548884.1 |
NR1H4 |
nuclear receptor subfamily 1, group H, member 4 |
chr3_+_186330712 | 2.58 |
ENST00000411641.2 ENST00000273784.5 |
AHSG |
alpha-2-HS-glycoprotein |
chr4_-_186733363 | 2.57 |
ENST00000393523.2 ENST00000393528.3 ENST00000449407.2 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr10_-_90751038 | 2.57 |
ENST00000458159.1 ENST00000415557.1 ENST00000458208.1 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
chr11_+_844067 | 2.53 |
ENST00000397406.1 ENST00000409543.2 ENST00000525201.1 |
TSPAN4 |
tetraspanin 4 |
chr11_+_46402297 | 2.52 |
ENST00000405308.2 |
MDK |
midkine (neurite growth-promoting factor 2) |
chr12_+_100867694 | 2.49 |
ENST00000392986.3 ENST00000549996.1 |
NR1H4 |
nuclear receptor subfamily 1, group H, member 4 |
chr7_-_95064264 | 2.40 |
ENST00000536183.1 ENST00000433091.2 ENST00000222572.3 |
PON2 |
paraoxonase 2 |
chr4_-_110723194 | 2.38 |
ENST00000394635.3 |
CFI |
complement factor I |
chr14_-_94789663 | 2.37 |
ENST00000557225.1 ENST00000341584.3 |
SERPINA6 |
serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 6 |
chr19_+_18496957 | 2.37 |
ENST00000252809.3 |
GDF15 |
growth differentiation factor 15 |
chr12_-_71551868 | 2.34 |
ENST00000247829.3 |
TSPAN8 |
tetraspanin 8 |
chr2_+_163175394 | 2.32 |
ENST00000446271.1 ENST00000429691.2 |
GCA |
grancalcin, EF-hand calcium binding protein |
chr18_+_3449695 | 2.30 |
ENST00000343820.5 |
TGIF1 |
TGFB-induced factor homeobox 1 |
chr11_+_46402482 | 2.28 |
ENST00000441869.1 |
MDK |
midkine (neurite growth-promoting factor 2) |
chr1_+_207262881 | 2.25 |
ENST00000451804.2 |
C4BPB |
complement component 4 binding protein, beta |
chr2_+_177053307 | 2.22 |
ENST00000331462.4 |
HOXD1 |
homeobox D1 |
chr9_-_94124171 | 2.21 |
ENST00000422391.2 ENST00000375731.4 ENST00000303617.5 |
AUH |
AU RNA binding protein/enoyl-CoA hydratase |
chr2_+_97481974 | 2.19 |
ENST00000377060.3 ENST00000305510.3 |
CNNM3 |
cyclin M3 |
chr18_+_29171689 | 2.14 |
ENST00000237014.3 |
TTR |
transthyretin |
chr3_-_185826855 | 2.14 |
ENST00000306376.5 |
ETV5 |
ets variant 5 |
chr17_+_26662730 | 2.13 |
ENST00000226225.2 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr12_+_66217911 | 2.10 |
ENST00000403681.2 |
HMGA2 |
high mobility group AT-hook 2 |
chr10_+_31610064 | 2.08 |
ENST00000446923.2 ENST00000559476.1 |
ZEB1 |
zinc finger E-box binding homeobox 1 |
chrX_+_146993534 | 2.04 |
ENST00000334557.6 ENST00000439526.2 ENST00000370475.4 |
FMR1 |
fragile X mental retardation 1 |
chr20_+_306177 | 2.03 |
ENST00000544632.1 |
SOX12 |
SRY (sex determining region Y)-box 12 |
chr11_-_111781554 | 2.00 |
ENST00000526167.1 ENST00000528961.1 |
CRYAB |
crystallin, alpha B |
chr8_+_70404996 | 1.99 |
ENST00000402687.4 ENST00000419716.3 |
SULF1 |
sulfatase 1 |
chr2_+_201170596 | 1.98 |
ENST00000439084.1 ENST00000409718.1 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr10_-_69597915 | 1.97 |
ENST00000225171.2 |
DNAJC12 |
DnaJ (Hsp40) homolog, subfamily C, member 12 |
chr3_-_123512688 | 1.94 |
ENST00000475616.1 |
MYLK |
myosin light chain kinase |
chr1_-_12677714 | 1.91 |
ENST00000376223.2 |
DHRS3 |
dehydrogenase/reductase (SDR family) member 3 |
chr11_-_111781610 | 1.90 |
ENST00000525823.1 |
CRYAB |
crystallin, alpha B |
chr1_-_169555779 | 1.90 |
ENST00000367797.3 ENST00000367796.3 |
F5 |
coagulation factor V (proaccelerin, labile factor) |
chr4_-_70080449 | 1.89 |
ENST00000446444.1 |
UGT2B11 |
UDP glucuronosyltransferase 2 family, polypeptide B11 |
chr18_+_55888767 | 1.87 |
ENST00000431212.2 ENST00000586268.1 ENST00000587190.1 |
NEDD4L |
neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase |
chr20_-_43150601 | 1.86 |
ENST00000541235.1 ENST00000255175.1 ENST00000342374.4 |
SERINC3 |
serine incorporator 3 |
chr20_-_50384864 | 1.85 |
ENST00000311637.5 ENST00000402822.1 |
ATP9A |
ATPase, class II, type 9A |
chr10_+_5135981 | 1.85 |
ENST00000380554.3 |
AKR1C3 |
aldo-keto reductase family 1, member C3 |
chr16_+_72088376 | 1.84 |
ENST00000570083.1 ENST00000355906.5 ENST00000398131.2 ENST00000569639.1 ENST00000564499.1 ENST00000357763.4 ENST00000562526.1 ENST00000565574.1 ENST00000568417.2 ENST00000356967.5 |
HP HPR |
haptoglobin haptoglobin-related protein |
chr2_-_190927447 | 1.79 |
ENST00000260950.4 |
MSTN |
myostatin |
chrX_-_20236970 | 1.71 |
ENST00000379548.4 |
RPS6KA3 |
ribosomal protein S6 kinase, 90kDa, polypeptide 3 |
chr3_-_148939835 | 1.71 |
ENST00000264613.6 |
CP |
ceruloplasmin (ferroxidase) |
chr6_+_89791507 | 1.71 |
ENST00000354922.3 |
PNRC1 |
proline-rich nuclear receptor coactivator 1 |
chr4_-_155533787 | 1.71 |
ENST00000407946.1 ENST00000405164.1 ENST00000336098.3 ENST00000393846.2 ENST00000404648.3 ENST00000443553.1 |
FGG |
fibrinogen gamma chain |
chr16_-_87970122 | 1.69 |
ENST00000309893.2 |
CA5A |
carbonic anhydrase VA, mitochondrial |
chr17_+_79953310 | 1.69 |
ENST00000582355.2 |
ASPSCR1 |
alveolar soft part sarcoma chromosome region, candidate 1 |
chr4_-_89744457 | 1.68 |
ENST00000395002.2 |
FAM13A |
family with sequence similarity 13, member A |
chr10_-_45474237 | 1.68 |
ENST00000448778.1 ENST00000298295.3 |
C10orf10 |
chromosome 10 open reading frame 10 |
chr6_-_41715128 | 1.67 |
ENST00000356667.4 ENST00000373025.3 ENST00000425343.2 |
PGC |
progastricsin (pepsinogen C) |
chrX_-_10851762 | 1.67 |
ENST00000380785.1 ENST00000380787.1 |
MID1 |
midline 1 (Opitz/BBB syndrome) |
chr13_-_67802549 | 1.66 |
ENST00000328454.5 ENST00000377865.2 |
PCDH9 |
protocadherin 9 |
chr1_+_229440129 | 1.65 |
ENST00000366688.3 |
SPHAR |
S-phase response (cyclin related) |
chr2_+_11674213 | 1.64 |
ENST00000381486.2 |
GREB1 |
growth regulation by estrogen in breast cancer 1 |
chr3_+_133465228 | 1.63 |
ENST00000482271.1 ENST00000264998.3 |
TF |
transferrin |
chr4_+_74275057 | 1.63 |
ENST00000511370.1 |
ALB |
albumin |
chr4_-_186732048 | 1.60 |
ENST00000448662.2 ENST00000439049.1 ENST00000420158.1 ENST00000431808.1 ENST00000319471.9 |
SORBS2 |
sorbin and SH3 domain containing 2 |
chr11_+_117073850 | 1.60 |
ENST00000529622.1 |
TAGLN |
transgelin |
chr7_+_106809406 | 1.60 |
ENST00000468410.1 ENST00000478930.1 ENST00000464009.1 ENST00000222574.4 |
HBP1 |
HMG-box transcription factor 1 |
chr2_+_189839046 | 1.59 |
ENST00000304636.3 ENST00000317840.5 |
COL3A1 |
collagen, type III, alpha 1 |
chr12_-_111926342 | 1.59 |
ENST00000389154.3 |
ATXN2 |
ataxin 2 |
chr2_-_190044480 | 1.58 |
ENST00000374866.3 |
COL5A2 |
collagen, type V, alpha 2 |
chr10_+_7745232 | 1.58 |
ENST00000358415.4 |
ITIH2 |
inter-alpha-trypsin inhibitor heavy chain 2 |
chr9_+_504674 | 1.57 |
ENST00000382297.2 |
KANK1 |
KN motif and ankyrin repeat domains 1 |
chr12_+_96588143 | 1.54 |
ENST00000228741.3 ENST00000547249.1 |
ELK3 |
ELK3, ETS-domain protein (SRF accessory protein 2) |
chr3_+_158787041 | 1.53 |
ENST00000471575.1 ENST00000476809.1 ENST00000485419.1 |
IQCJ-SCHIP1 |
IQCJ-SCHIP1 readthrough |
chr8_-_119124045 | 1.51 |
ENST00000378204.2 |
EXT1 |
exostosin glycosyltransferase 1 |
chr1_-_57431679 | 1.51 |
ENST00000371237.4 ENST00000535057.1 ENST00000543257.1 |
C8B |
complement component 8, beta polypeptide |
chr5_-_78281603 | 1.51 |
ENST00000264914.4 |
ARSB |
arylsulfatase B |
chr10_-_92681033 | 1.50 |
ENST00000371697.3 |
ANKRD1 |
ankyrin repeat domain 1 (cardiac muscle) |
chr7_+_134576151 | 1.50 |
ENST00000393118.2 |
CALD1 |
caldesmon 1 |
chr9_-_116840728 | 1.49 |
ENST00000265132.3 |
AMBP |
alpha-1-microglobulin/bikunin precursor |
chr17_-_7082861 | 1.48 |
ENST00000269299.3 |
ASGR1 |
asialoglycoprotein receptor 1 |
chr13_-_41240717 | 1.48 |
ENST00000379561.5 |
FOXO1 |
forkhead box O1 |
chr6_+_123110465 | 1.48 |
ENST00000539041.1 |
SMPDL3A |
sphingomyelin phosphodiesterase, acid-like 3A |
chr6_-_52859046 | 1.47 |
ENST00000457564.1 ENST00000541324.1 ENST00000370960.1 |
GSTA4 |
glutathione S-transferase alpha 4 |
chr12_-_91539918 | 1.47 |
ENST00000548218.1 |
DCN |
decorin |
chr6_-_56707943 | 1.46 |
ENST00000370769.4 ENST00000421834.2 ENST00000312431.6 ENST00000361203.3 ENST00000523817.1 |
DST |
dystonin |
chr1_+_207262540 | 1.46 |
ENST00000452902.2 |
C4BPB |
complement component 4 binding protein, beta |
chr1_-_57045228 | 1.46 |
ENST00000371250.3 |
PPAP2B |
phosphatidic acid phosphatase type 2B |
chr4_+_155484155 | 1.46 |
ENST00000509493.1 |
FGB |
fibrinogen beta chain |
chr16_-_84150492 | 1.46 |
ENST00000343411.3 |
MBTPS1 |
membrane-bound transcription factor peptidase, site 1 |
chr17_+_26662597 | 1.46 |
ENST00000544907.2 |
TNFAIP1 |
tumor necrosis factor, alpha-induced protein 1 (endothelial) |
chr2_+_201450591 | 1.46 |
ENST00000374700.2 |
AOX1 |
aldehyde oxidase 1 |
chrX_-_128657457 | 1.45 |
ENST00000371121.3 ENST00000371123.1 ENST00000371122.4 |
SMARCA1 |
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 1 |
chr3_-_185538849 | 1.45 |
ENST00000421047.2 |
IGF2BP2 |
insulin-like growth factor 2 mRNA binding protein 2 |
chr10_+_111985713 | 1.45 |
ENST00000239007.7 |
MXI1 |
MAX interactor 1, dimerization protein |
chr12_-_103310987 | 1.45 |
ENST00000307000.2 |
PAH |
phenylalanine hydroxylase |
chr13_+_73629107 | 1.44 |
ENST00000539231.1 |
KLF5 |
Kruppel-like factor 5 (intestinal) |
chr8_-_13372395 | 1.44 |
ENST00000276297.4 ENST00000511869.1 |
DLC1 |
deleted in liver cancer 1 |
chr2_-_163099885 | 1.43 |
ENST00000443424.1 |
FAP |
fibroblast activation protein, alpha |
chr11_-_111781454 | 1.41 |
ENST00000533280.1 |
CRYAB |
crystallin, alpha B |
chr3_-_149093499 | 1.41 |
ENST00000472441.1 |
TM4SF1 |
transmembrane 4 L six family member 1 |
chr4_+_124317940 | 1.39 |
ENST00000505319.1 ENST00000339241.1 |
SPRY1 |
sprouty homolog 1, antagonist of FGF signaling (Drosophila) |
chr1_-_109935819 | 1.39 |
ENST00000538502.1 |
SORT1 |
sortilin 1 |
chr1_+_214161854 | 1.39 |
ENST00000435016.1 |
PROX1 |
prospero homeobox 1 |
chr21_-_43735446 | 1.38 |
ENST00000398431.2 |
TFF3 |
trefoil factor 3 (intestinal) |
chr2_-_88427568 | 1.38 |
ENST00000393750.3 ENST00000295834.3 |
FABP1 |
fatty acid binding protein 1, liver |
chr1_+_100111479 | 1.37 |
ENST00000263174.4 |
PALMD |
palmdelphin |
chr22_+_21128167 | 1.37 |
ENST00000215727.5 |
SERPIND1 |
serpin peptidase inhibitor, clade D (heparin cofactor), member 1 |
chr2_-_163100045 | 1.37 |
ENST00000188790.4 |
FAP |
fibroblast activation protein, alpha |
chr15_+_81071684 | 1.36 |
ENST00000220244.3 ENST00000394685.3 ENST00000356249.5 |
KIAA1199 |
KIAA1199 |
chr17_+_66521936 | 1.35 |
ENST00000592800.1 |
PRKAR1A |
protein kinase, cAMP-dependent, regulatory, type I, alpha |
chr9_-_135819987 | 1.35 |
ENST00000298552.3 ENST00000403810.1 |
TSC1 |
tuberous sclerosis 1 |
chr16_+_14980632 | 1.34 |
ENST00000565655.1 |
NOMO1 |
NODAL modulator 1 |
chr12_+_53491220 | 1.34 |
ENST00000548547.1 ENST00000301464.3 |
IGFBP6 |
insulin-like growth factor binding protein 6 |
chr1_+_207262170 | 1.33 |
ENST00000367078.3 |
C4BPB |
complement component 4 binding protein, beta |
chr1_+_162602244 | 1.33 |
ENST00000367922.3 ENST00000367921.3 |
DDR2 |
discoidin domain receptor tyrosine kinase 2 |
chr1_-_153599732 | 1.31 |
ENST00000392623.1 |
S100A13 |
S100 calcium binding protein A13 |
chr20_+_44519948 | 1.31 |
ENST00000354880.5 ENST00000191018.5 |
CTSA |
cathepsin A |
chr20_+_306221 | 1.31 |
ENST00000342665.2 |
SOX12 |
SRY (sex determining region Y)-box 12 |
chr1_+_207262627 | 1.31 |
ENST00000391923.1 |
C4BPB |
complement component 4 binding protein, beta |
chr2_+_192141611 | 1.28 |
ENST00000392316.1 |
MYO1B |
myosin IB |
chr8_-_27472198 | 1.28 |
ENST00000519472.1 ENST00000523589.1 ENST00000522413.1 ENST00000523396.1 ENST00000560366.1 |
CLU |
clusterin |
chr3_+_190333097 | 1.27 |
ENST00000412080.1 |
IL1RAP |
interleukin 1 receptor accessory protein |
chrX_-_132887729 | 1.26 |
ENST00000406757.2 |
GPC3 |
glypican 3 |
chr4_+_166300084 | 1.26 |
ENST00000402744.4 |
CPE |
carboxypeptidase E |
chr11_-_116708302 | 1.25 |
ENST00000375320.1 ENST00000359492.2 ENST00000375329.2 ENST00000375323.1 |
APOA1 |
apolipoprotein A-I |
chr10_-_69597810 | 1.25 |
ENST00000483798.2 |
DNAJC12 |
DnaJ (Hsp40) homolog, subfamily C, member 12 |
chrX_+_105937068 | 1.24 |
ENST00000324342.3 |
RNF128 |
ring finger protein 128, E3 ubiquitin protein ligase |
chr4_-_70361615 | 1.24 |
ENST00000305107.6 |
UGT2B4 |
UDP glucuronosyltransferase 2 family, polypeptide B4 |
chr17_+_58755184 | 1.23 |
ENST00000589222.1 ENST00000407086.3 ENST00000390652.5 |
BCAS3 |
breast carcinoma amplified sequence 3 |
chr2_-_175711133 | 1.22 |
ENST00000409597.1 ENST00000413882.1 |
CHN1 |
chimerin 1 |
chr14_-_53331239 | 1.22 |
ENST00000553663.1 |
FERMT2 |
fermitin family member 2 |
chr7_+_102553430 | 1.21 |
ENST00000339431.4 ENST00000249377.4 |
LRRC17 |
leucine rich repeat containing 17 |
chr20_+_44520009 | 1.21 |
ENST00000607482.1 ENST00000372459.2 |
CTSA |
cathepsin A |
chr13_+_102142296 | 1.21 |
ENST00000376162.3 |
ITGBL1 |
integrin, beta-like 1 (with EGF-like repeat domains) |
chr12_-_91576561 | 1.20 |
ENST00000547568.2 ENST00000552962.1 |
DCN |
decorin |
chr12_-_96390063 | 1.20 |
ENST00000541929.1 |
HAL |
histidine ammonia-lyase |
chr2_+_228678550 | 1.20 |
ENST00000409189.3 ENST00000358813.4 |
CCL20 |
chemokine (C-C motif) ligand 20 |
chr16_-_75467318 | 1.19 |
ENST00000283882.3 |
CFDP1 |
craniofacial development protein 1 |
chr11_-_18258342 | 1.18 |
ENST00000278222.4 |
SAA4 |
serum amyloid A4, constitutive |
chr2_+_201171242 | 1.18 |
ENST00000360760.5 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr3_-_99569821 | 1.17 |
ENST00000487087.1 |
FILIP1L |
filamin A interacting protein 1-like |
chr10_-_93392811 | 1.17 |
ENST00000238994.5 |
PPP1R3C |
protein phosphatase 1, regulatory subunit 3C |
chr20_+_44035200 | 1.16 |
ENST00000372717.1 ENST00000360981.4 |
DBNDD2 |
dysbindin (dystrobrevin binding protein 1) domain containing 2 |
chr14_-_74551172 | 1.16 |
ENST00000553458.1 |
ALDH6A1 |
aldehyde dehydrogenase 6 family, member A1 |
chr20_-_22566089 | 1.15 |
ENST00000377115.4 |
FOXA2 |
forkhead box A2 |
chr11_-_35287243 | 1.15 |
ENST00000464522.2 |
SLC1A2 |
solute carrier family 1 (glial high affinity glutamate transporter), member 2 |
chr3_+_147127142 | 1.14 |
ENST00000282928.4 |
ZIC1 |
Zic family member 1 |
chr5_+_34757309 | 1.14 |
ENST00000397449.1 |
RAI14 |
retinoic acid induced 14 |
chr8_+_97597148 | 1.14 |
ENST00000521590.1 |
SDC2 |
syndecan 2 |
chr4_+_74301880 | 1.13 |
ENST00000395792.2 ENST00000226359.2 |
AFP |
alpha-fetoprotein |
chr14_+_24583836 | 1.12 |
ENST00000559115.1 ENST00000558215.1 ENST00000557810.1 ENST00000561375.1 ENST00000446197.3 ENST00000559796.1 ENST00000560713.1 ENST00000560901.1 ENST00000559382.1 |
DCAF11 |
DDB1 and CUL4 associated factor 11 |
chrX_+_37208540 | 1.12 |
ENST00000466533.1 ENST00000542554.1 ENST00000543642.1 ENST00000484460.1 ENST00000449135.2 ENST00000463135.1 ENST00000465127.1 |
PRRG1 TM4SF2 |
proline rich Gla (G-carboxyglutamic acid) 1 Uncharacterized protein; cDNA FLJ59144, highly similar to Tetraspanin-7 |
chr1_-_173174681 | 1.11 |
ENST00000367718.1 |
TNFSF4 |
tumor necrosis factor (ligand) superfamily, member 4 |
chr2_+_201170770 | 1.11 |
ENST00000409988.3 ENST00000409385.1 |
SPATS2L |
spermatogenesis associated, serine-rich 2-like |
chr10_-_90712520 | 1.10 |
ENST00000224784.6 |
ACTA2 |
actin, alpha 2, smooth muscle, aorta |
chr3_-_99833333 | 1.09 |
ENST00000354552.3 ENST00000331335.5 ENST00000398326.2 |
FILIP1L |
filamin A interacting protein 1-like |
chrX_+_135251783 | 1.08 |
ENST00000394153.2 |
FHL1 |
four and a half LIM domains 1 |
chr4_-_70361579 | 1.08 |
ENST00000512583.1 |
UGT2B4 |
UDP glucuronosyltransferase 2 family, polypeptide B4 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.2 | 6.7 | GO:0060620 | regulation of cholesterol import(GO:0060620) negative regulation of cholesterol import(GO:0060621) regulation of sterol import(GO:2000909) negative regulation of sterol import(GO:2000910) |
2.0 | 11.9 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
2.0 | 9.8 | GO:0030070 | insulin processing(GO:0030070) |
1.7 | 5.1 | GO:0001079 | nitrogen catabolite regulation of transcription from RNA polymerase II promoter(GO:0001079) nitrogen catabolite activation of transcription from RNA polymerase II promoter(GO:0001080) regulation of urea metabolic process(GO:0034255) intracellular bile acid receptor signaling pathway(GO:0038185) interleukin-17 secretion(GO:0072615) nitrogen catabolite regulation of transcription(GO:0090293) nitrogen catabolite activation of transcription(GO:0090294) regulation of nitrogen cycle metabolic process(GO:1903314) positive regulation of glutamate metabolic process(GO:2000213) regulation of ammonia assimilation cycle(GO:2001248) positive regulation of ammonia assimilation cycle(GO:2001250) |
1.6 | 9.4 | GO:0010908 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition(GO:0044334) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
1.6 | 4.7 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
1.3 | 10.5 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
1.2 | 1.2 | GO:0010903 | negative regulation of very-low-density lipoprotein particle remodeling(GO:0010903) |
1.1 | 9.8 | GO:1903027 | regulation of opsonization(GO:1903027) |
1.1 | 4.3 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
1.0 | 10.9 | GO:0051918 | negative regulation of fibrinolysis(GO:0051918) |
0.8 | 4.8 | GO:0030421 | defecation(GO:0030421) |
0.8 | 4.0 | GO:0006651 | diacylglycerol biosynthetic process(GO:0006651) |
0.8 | 4.7 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.8 | 2.3 | GO:0006711 | estrogen catabolic process(GO:0006711) |
0.8 | 2.3 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.7 | 1.5 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.7 | 7.7 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
0.7 | 2.1 | GO:2000685 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.7 | 2.8 | GO:0097325 | melanocyte proliferation(GO:0097325) |
0.7 | 1.4 | GO:0070858 | negative regulation of bile acid biosynthetic process(GO:0070858) negative regulation of bile acid metabolic process(GO:1904252) |
0.7 | 2.0 | GO:0046113 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) nucleobase catabolic process(GO:0046113) |
0.6 | 2.5 | GO:0032571 | response to vitamin K(GO:0032571) |
0.6 | 1.8 | GO:0016095 | polyprenol catabolic process(GO:0016095) |
0.6 | 1.8 | GO:2000296 | negative regulation of hydrogen peroxide catabolic process(GO:2000296) |
0.6 | 3.0 | GO:1901252 | regulation of intracellular transport of viral material(GO:1901252) |
0.6 | 7.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.6 | 3.5 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
0.6 | 2.9 | GO:2001288 | positive regulation of caveolin-mediated endocytosis(GO:2001288) |
0.6 | 2.8 | GO:2000809 | positive regulation of synaptic vesicle clustering(GO:2000809) |
0.5 | 2.7 | GO:0044855 | plasma membrane raft distribution(GO:0044855) plasma membrane raft localization(GO:0044856) plasma membrane raft polarization(GO:0044858) regulation of plasma membrane raft polarization(GO:1903906) |
0.5 | 2.1 | GO:0007525 | somatic muscle development(GO:0007525) |
0.5 | 1.6 | GO:2000393 | negative regulation of lamellipodium morphogenesis(GO:2000393) |
0.5 | 3.5 | GO:1901529 | positive regulation of anion channel activity(GO:1901529) |
0.5 | 1.9 | GO:0035026 | leading edge cell differentiation(GO:0035026) |
0.5 | 1.4 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.5 | 1.8 | GO:0002215 | defense response to nematode(GO:0002215) T-helper 2 cell activation(GO:0035712) regulation of T-helper 2 cell activation(GO:2000569) positive regulation of T-helper 2 cell activation(GO:2000570) |
0.5 | 2.3 | GO:0097338 | response to clozapine(GO:0097338) |
0.4 | 1.8 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.4 | 2.1 | GO:0048133 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) germline stem cell asymmetric division(GO:0098728) |
0.4 | 2.5 | GO:2000158 | positive regulation of ubiquitin-specific protease activity(GO:2000158) |
0.4 | 1.3 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.4 | 1.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.4 | 1.6 | GO:0060686 | negative regulation of prostatic bud formation(GO:0060686) |
0.4 | 1.2 | GO:0045362 | regulation of interleukin-1 biosynthetic process(GO:0045360) positive regulation of interleukin-1 biosynthetic process(GO:0045362) |
0.4 | 1.6 | GO:1903224 | regulation of endodermal cell differentiation(GO:1903224) |
0.4 | 1.2 | GO:0045014 | carbon catabolite repression of transcription(GO:0045013) negative regulation of transcription by glucose(GO:0045014) |
0.4 | 2.5 | GO:0008218 | bioluminescence(GO:0008218) |
0.4 | 1.4 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.3 | 1.0 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.3 | 3.3 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
0.3 | 3.0 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.3 | 1.3 | GO:0001519 | peptide amidation(GO:0001519) protein amidation(GO:0018032) peptide modification(GO:0031179) |
0.3 | 1.3 | GO:0072180 | mesonephric duct morphogenesis(GO:0072180) |
0.3 | 0.9 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 2.7 | GO:0035542 | regulation of SNARE complex assembly(GO:0035542) |
0.3 | 1.5 | GO:1902617 | response to fluoride(GO:1902617) |
0.3 | 5.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.3 | 1.4 | GO:0051029 | rRNA transport(GO:0051029) |
0.3 | 1.1 | GO:0035720 | intraciliary anterograde transport(GO:0035720) |
0.3 | 0.8 | GO:0090427 | activation of meiosis(GO:0090427) |
0.3 | 1.7 | GO:0002760 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
0.3 | 0.8 | GO:0061188 | negative regulation of chromatin silencing at rDNA(GO:0061188) histone H3-K27 demethylation(GO:0071557) |
0.3 | 1.6 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.3 | 0.3 | GO:0032878 | regulation of establishment or maintenance of cell polarity(GO:0032878) |
0.3 | 0.8 | GO:0052250 | modulation of signal transduction in other organism(GO:0044501) modulation by symbiont of host signal transduction pathway(GO:0052027) modulation of signal transduction in other organism involved in symbiotic interaction(GO:0052250) modulation by symbiont of host I-kappaB kinase/NF-kappaB cascade(GO:0085032) |
0.3 | 1.9 | GO:0009597 | detection of virus(GO:0009597) |
0.3 | 0.8 | GO:1904647 | response to rotenone(GO:1904647) |
0.3 | 2.1 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.3 | 2.0 | GO:0038063 | collagen-activated tyrosine kinase receptor signaling pathway(GO:0038063) |
0.2 | 0.7 | GO:0098746 | fast, calcium ion-dependent exocytosis of neurotransmitter(GO:0098746) |
0.2 | 1.5 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.2 | 0.5 | GO:1990164 | histone H2A phosphorylation(GO:1990164) |
0.2 | 14.4 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.2 | 1.2 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.7 | GO:0001544 | initiation of primordial ovarian follicle growth(GO:0001544) |
0.2 | 0.7 | GO:0006617 | SRP-dependent cotranslational protein targeting to membrane, signal sequence recognition(GO:0006617) |
0.2 | 0.9 | GO:1903288 | protein transport into plasma membrane raft(GO:0044861) positive regulation of potassium ion import(GO:1903288) |
0.2 | 0.9 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.2 | 1.4 | GO:0038172 | interleukin-33-mediated signaling pathway(GO:0038172) |
0.2 | 0.7 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.2 | 1.1 | GO:0051611 | negative regulation of neurotransmitter uptake(GO:0051581) serotonin uptake(GO:0051610) regulation of serotonin uptake(GO:0051611) negative regulation of serotonin uptake(GO:0051612) |
0.2 | 3.2 | GO:0032060 | bleb assembly(GO:0032060) |
0.2 | 1.7 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 1.3 | GO:0061518 | macrophage proliferation(GO:0061517) microglial cell proliferation(GO:0061518) regulation of neuronal signal transduction(GO:1902847) positive regulation of neurofibrillary tangle assembly(GO:1902998) |
0.2 | 2.7 | GO:0035372 | protein localization to microtubule(GO:0035372) |
0.2 | 1.4 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.2 | 1.8 | GO:0006552 | leucine catabolic process(GO:0006552) |
0.2 | 2.0 | GO:0050703 | interleukin-1 alpha secretion(GO:0050703) |
0.2 | 2.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.2 | 0.8 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
0.2 | 0.8 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.2 | 1.0 | GO:0046391 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.2 | 1.0 | GO:0010751 | negative regulation of nitric oxide mediated signal transduction(GO:0010751) |
0.2 | 1.8 | GO:1904715 | negative regulation of chaperone-mediated autophagy(GO:1904715) |
0.2 | 1.9 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
0.2 | 0.6 | GO:0019477 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.2 | 4.4 | GO:0035024 | negative regulation of Rho protein signal transduction(GO:0035024) |
0.2 | 1.1 | GO:1904721 | negative regulation of mRNA cleavage(GO:0031438) negative regulation of immunoglobulin secretion(GO:0051025) negative regulation of ribonuclease activity(GO:0060701) negative regulation of endoribonuclease activity(GO:0060702) negative regulation of mRNA endonucleolytic cleavage involved in unfolded protein response(GO:1904721) |
0.2 | 1.4 | GO:0061302 | smooth muscle cell-matrix adhesion(GO:0061302) |
0.2 | 1.2 | GO:0070294 | renal sodium ion absorption(GO:0070294) |
0.2 | 0.3 | GO:0034626 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.2 | 1.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.2 | 1.4 | GO:2000270 | negative regulation of fibroblast apoptotic process(GO:2000270) |
0.2 | 0.7 | GO:0045872 | positive regulation of rhodopsin gene expression(GO:0045872) |
0.2 | 0.3 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 0.3 | GO:0005988 | lactose metabolic process(GO:0005988) lactose biosynthetic process(GO:0005989) |
0.2 | 1.5 | GO:0006685 | sphingomyelin catabolic process(GO:0006685) |
0.2 | 3.4 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.2 | 1.5 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.2 | 1.4 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.2 | 0.8 | GO:1900020 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.2 | 1.1 | GO:0042126 | nitrate metabolic process(GO:0042126) |
0.2 | 0.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.2 | 1.7 | GO:0010603 | regulation of cytoplasmic mRNA processing body assembly(GO:0010603) |
0.2 | 0.6 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.2 | 7.1 | GO:1900047 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
0.2 | 0.5 | GO:0007231 | osmosensory signaling pathway(GO:0007231) |
0.1 | 0.6 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.1 | 1.5 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.1 | 0.4 | GO:0072092 | ureteric bud invasion(GO:0072092) |
0.1 | 0.6 | GO:0006114 | glycerol biosynthetic process(GO:0006114) response to methionine(GO:1904640) |
0.1 | 1.2 | GO:0032287 | peripheral nervous system myelin maintenance(GO:0032287) |
0.1 | 0.6 | GO:0046223 | mycotoxin catabolic process(GO:0043387) aflatoxin catabolic process(GO:0046223) organic heteropentacyclic compound catabolic process(GO:1901377) regulation of glutathione biosynthetic process(GO:1903786) positive regulation of glutathione biosynthetic process(GO:1903788) |
0.1 | 1.1 | GO:0070779 | D-aspartate transport(GO:0070777) D-aspartate import(GO:0070779) |
0.1 | 0.4 | GO:1902938 | regulation of intracellular calcium activated chloride channel activity(GO:1902938) |
0.1 | 5.7 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.1 | GO:1902957 | negative regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902957) |
0.1 | 0.6 | GO:0071477 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.1 | 1.5 | GO:0036500 | ATF6-mediated unfolded protein response(GO:0036500) |
0.1 | 1.8 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.1 | 1.4 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.6 | GO:1903644 | regulation of chaperone-mediated protein folding(GO:1903644) |
0.1 | 1.2 | GO:1904352 | positive regulation of protein catabolic process in the vacuole(GO:1904352) |
0.1 | 0.7 | GO:1902897 | regulation of postsynaptic density protein 95 clustering(GO:1902897) |
0.1 | 0.1 | GO:2000412 | positive regulation of thymocyte migration(GO:2000412) |
0.1 | 0.4 | GO:0060535 | trachea cartilage morphogenesis(GO:0060535) |
0.1 | 0.9 | GO:2000795 | trigeminal sensory nucleus development(GO:0021730) principal sensory nucleus of trigeminal nerve development(GO:0021740) negative regulation of epithelial cell proliferation involved in lung morphogenesis(GO:2000795) |
0.1 | 2.0 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 1.5 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.1 | 1.1 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.1 | 1.0 | GO:0006987 | activation of signaling protein activity involved in unfolded protein response(GO:0006987) |
0.1 | 1.0 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
0.1 | 0.5 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 1.8 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.1 | 1.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.1 | 0.6 | GO:0010499 | proteasomal ubiquitin-independent protein catabolic process(GO:0010499) |
0.1 | 1.3 | GO:0051599 | response to hydrostatic pressure(GO:0051599) |
0.1 | 0.4 | GO:1901876 | regulation of calcium ion binding(GO:1901876) negative regulation of calcium ion binding(GO:1901877) |
0.1 | 0.4 | GO:0052314 | serotonin biosynthetic process(GO:0042427) phytoalexin metabolic process(GO:0052314) |
0.1 | 1.8 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.1 | 1.6 | GO:0006768 | biotin metabolic process(GO:0006768) |
0.1 | 0.8 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.1 | 0.6 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.1 | 0.4 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.1 | 0.6 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.1 | 0.3 | GO:0072137 | condensed mesenchymal cell proliferation(GO:0072137) |
0.1 | 2.1 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.1 | 0.4 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) |
0.1 | 0.3 | GO:0035623 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) pronephros morphogenesis(GO:0072114) |
0.1 | 0.3 | GO:0046521 | sphingoid catabolic process(GO:0046521) |
0.1 | 0.3 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.1 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.1 | 1.6 | GO:1902221 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.1 | 0.8 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.1 | 1.6 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.1 | 2.5 | GO:0045332 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
0.1 | 0.4 | GO:0060849 | regulation of transcription involved in lymphatic endothelial cell fate commitment(GO:0060849) |
0.1 | 0.9 | GO:0033089 | positive regulation of T cell differentiation in thymus(GO:0033089) positive regulation of thymocyte aggregation(GO:2000400) |
0.1 | 0.6 | GO:0034201 | response to oleic acid(GO:0034201) |
0.1 | 2.0 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.1 | 0.5 | GO:2001034 | positive regulation of double-strand break repair via nonhomologous end joining(GO:2001034) |
0.1 | 0.3 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.1 | 0.5 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 0.3 | GO:0032474 | otolith morphogenesis(GO:0032474) |
0.1 | 0.4 | GO:0006447 | regulation of translational initiation by iron(GO:0006447) |
0.1 | 0.4 | GO:0036101 | leukotriene catabolic process(GO:0036100) leukotriene B4 catabolic process(GO:0036101) leukotriene B4 metabolic process(GO:0036102) icosanoid catabolic process(GO:1901523) fatty acid derivative catabolic process(GO:1901569) |
0.1 | 0.4 | GO:0038018 | Wnt receptor catabolic process(GO:0038018) |
0.1 | 0.4 | GO:0030047 | actin modification(GO:0030047) |
0.1 | 0.5 | GO:0044211 | CTP salvage(GO:0044211) |
0.1 | 4.6 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.1 | 1.3 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
0.1 | 0.5 | GO:0009820 | alkaloid metabolic process(GO:0009820) |
0.1 | 0.8 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.1 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 11.5 | GO:0021987 | cerebral cortex development(GO:0021987) |
0.1 | 0.3 | GO:0003072 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.3 | GO:1900063 | regulation of peroxisome organization(GO:1900063) |
0.1 | 0.3 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.6 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.1 | 0.5 | GO:0060244 | negative regulation of cell proliferation involved in contact inhibition(GO:0060244) |
0.1 | 1.1 | GO:1904776 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.1 | 3.1 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.1 | 0.2 | GO:0045659 | regulation of eosinophil differentiation(GO:0045643) positive regulation of eosinophil differentiation(GO:0045645) regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.1 | 0.2 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.1 | 0.5 | GO:0021540 | corpus callosum morphogenesis(GO:0021540) |
0.1 | 0.6 | GO:0019233 | sensory perception of pain(GO:0019233) |
0.1 | 0.5 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.1 | 0.5 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.1 | 2.1 | GO:0061049 | physiological muscle hypertrophy(GO:0003298) physiological cardiac muscle hypertrophy(GO:0003301) cell growth involved in cardiac muscle cell development(GO:0061049) |
0.1 | 0.3 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.1 | 0.3 | GO:2000660 | negative regulation of interleukin-1-mediated signaling pathway(GO:2000660) |
0.1 | 0.1 | GO:0007518 | myoblast fate determination(GO:0007518) |
0.1 | 0.7 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) |
0.1 | 0.1 | GO:1905065 | regulation of vascular smooth muscle cell differentiation(GO:1905063) positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
0.1 | 0.1 | GO:0090315 | negative regulation of protein targeting to membrane(GO:0090315) |
0.1 | 0.4 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.1 | 0.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.1 | 1.9 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.1 | 0.6 | GO:0002249 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 0.1 | GO:0016999 | antibiotic metabolic process(GO:0016999) |
0.1 | 0.3 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) positive regulation of hexokinase activity(GO:1903301) |
0.1 | 0.2 | GO:0050760 | negative regulation of thymidylate synthase biosynthetic process(GO:0050760) |
0.1 | 3.3 | GO:0043268 | positive regulation of potassium ion transport(GO:0043268) |
0.1 | 0.3 | GO:0060363 | cranial suture morphogenesis(GO:0060363) |
0.1 | 0.3 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
0.1 | 0.7 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.1 | 0.5 | GO:0009414 | response to water deprivation(GO:0009414) |
0.1 | 0.9 | GO:0061162 | establishment of monopolar cell polarity(GO:0061162) establishment or maintenance of monopolar cell polarity(GO:0061339) |
0.1 | 1.7 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.3 | GO:0006664 | glycolipid metabolic process(GO:0006664) liposaccharide metabolic process(GO:1903509) |
0.1 | 0.2 | GO:2000395 | ubiquitin-dependent endocytosis(GO:0070086) regulation of ubiquitin-dependent endocytosis(GO:2000395) positive regulation of ubiquitin-dependent endocytosis(GO:2000397) |
0.1 | 0.6 | GO:0015825 | L-serine transport(GO:0015825) |
0.1 | 0.3 | GO:0032914 | positive regulation of transforming growth factor beta1 production(GO:0032914) |
0.1 | 2.8 | GO:0019835 | cytolysis(GO:0019835) |
0.1 | 0.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) |
0.1 | 0.8 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.1 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.1 | 0.2 | GO:0071934 | thiamine transport(GO:0015888) thiamine transmembrane transport(GO:0071934) |
0.1 | 0.2 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.1 | 0.1 | GO:1901624 | negative regulation of lymphocyte chemotaxis(GO:1901624) |
0.1 | 0.4 | GO:0072592 | oxygen metabolic process(GO:0072592) |
0.1 | 0.2 | GO:0002933 | lipid hydroxylation(GO:0002933) |
0.1 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.1 | 0.2 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.1 | 0.2 | GO:0044314 | protein K27-linked ubiquitination(GO:0044314) |
0.1 | 0.2 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
0.1 | 0.6 | GO:0071847 | TNFSF11-mediated signaling pathway(GO:0071847) |
0.1 | 0.9 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.5 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 0.5 | GO:0097435 | fibril organization(GO:0097435) |
0.1 | 0.3 | GO:0003183 | mitral valve morphogenesis(GO:0003183) |
0.1 | 0.8 | GO:0034497 | protein localization to pre-autophagosomal structure(GO:0034497) |
0.1 | 0.2 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 0.1 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.4 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
0.1 | 0.2 | GO:0060355 | positive regulation of cell adhesion molecule production(GO:0060355) |
0.1 | 0.1 | GO:0010040 | response to iron(II) ion(GO:0010040) |
0.1 | 0.2 | GO:0060294 | cilium movement involved in cell motility(GO:0060294) |
0.1 | 0.8 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.1 | 0.8 | GO:0045838 | positive regulation of membrane potential(GO:0045838) |
0.1 | 0.2 | GO:0010701 | positive regulation of norepinephrine secretion(GO:0010701) |
0.1 | 1.5 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.1 | 0.1 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
0.1 | 0.8 | GO:0016024 | CDP-diacylglycerol biosynthetic process(GO:0016024) |
0.1 | 0.2 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 2.2 | GO:0010862 | positive regulation of pathway-restricted SMAD protein phosphorylation(GO:0010862) |
0.1 | 1.0 | GO:0008045 | motor neuron axon guidance(GO:0008045) |
0.1 | 0.2 | GO:0006627 | protein processing involved in protein targeting to mitochondrion(GO:0006627) |
0.1 | 0.4 | GO:1903071 | positive regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903071) |
0.1 | 0.4 | GO:0070235 | regulation of activation-induced cell death of T cells(GO:0070235) negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.1 | 0.8 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.0 | 0.0 | GO:0033603 | positive regulation of dopamine secretion(GO:0033603) |
0.0 | 0.6 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.0 | 1.0 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.0 | 0.0 | GO:0018196 | peptidyl-asparagine modification(GO:0018196) |
0.0 | 1.0 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
0.0 | 1.3 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.4 | GO:0045852 | pH elevation(GO:0045852) intracellular pH elevation(GO:0051454) |
0.0 | 1.0 | GO:2000114 | regulation of establishment of cell polarity(GO:2000114) |
0.0 | 0.3 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.2 | GO:1902037 | negative regulation of hematopoietic stem cell differentiation(GO:1902037) |
0.0 | 0.2 | GO:0090292 | nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.0 | 3.6 | GO:0021510 | spinal cord development(GO:0021510) |
0.0 | 0.1 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
0.0 | 1.2 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.1 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.0 | 0.9 | GO:1902857 | positive regulation of nonmotile primary cilium assembly(GO:1902857) |
0.0 | 0.2 | GO:1903936 | response to sodium arsenite(GO:1903935) cellular response to sodium arsenite(GO:1903936) |
0.0 | 0.2 | GO:0030037 | actin filament reorganization involved in cell cycle(GO:0030037) |
0.0 | 0.0 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.0 | 0.9 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.5 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.0 | 0.1 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.0 | 0.0 | GO:2000211 | regulation of glutamate metabolic process(GO:2000211) |
0.0 | 0.1 | GO:0097156 | fasciculation of motor neuron axon(GO:0097156) |
0.0 | 0.3 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.0 | 0.1 | GO:0014824 | artery smooth muscle contraction(GO:0014824) |
0.0 | 0.3 | GO:0006701 | progesterone biosynthetic process(GO:0006701) |
0.0 | 0.3 | GO:0051012 | microtubule sliding(GO:0051012) |
0.0 | 0.0 | GO:0048840 | otolith development(GO:0048840) |
0.0 | 0.3 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 1.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.0 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.0 | 0.0 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.0 | 1.0 | GO:0000042 | protein targeting to Golgi(GO:0000042) |
0.0 | 2.0 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.0 | 1.1 | GO:0043555 | regulation of translation in response to stress(GO:0043555) |
0.0 | 0.2 | GO:1902260 | negative regulation of delayed rectifier potassium channel activity(GO:1902260) negative regulation of voltage-gated potassium channel activity(GO:1903817) |
0.0 | 0.2 | GO:0010536 | positive regulation of activation of Janus kinase activity(GO:0010536) |
0.0 | 16.3 | GO:0006936 | muscle contraction(GO:0006936) |
0.0 | 0.9 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.0 | 0.4 | GO:0010592 | positive regulation of lamellipodium assembly(GO:0010592) |
0.0 | 0.4 | GO:0035826 | rubidium ion transport(GO:0035826) regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
0.0 | 0.1 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.0 | 0.5 | GO:0006853 | carnitine shuttle(GO:0006853) |
0.0 | 0.1 | GO:0036058 | filtration diaphragm assembly(GO:0036058) slit diaphragm assembly(GO:0036060) negative regulation of retinal ganglion cell axon guidance(GO:0090260) |
0.0 | 0.1 | GO:1990535 | neuron projection maintenance(GO:1990535) |
0.0 | 0.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.0 | 0.1 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:0060335 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.0 | 0.1 | GO:0070857 | regulation of bile acid biosynthetic process(GO:0070857) |
0.0 | 0.7 | GO:0007191 | adenylate cyclase-activating dopamine receptor signaling pathway(GO:0007191) |
0.0 | 0.1 | GO:0032667 | interleukin-23 production(GO:0032627) regulation of interleukin-23 production(GO:0032667) positive regulation of interleukin-23 production(GO:0032747) |
0.0 | 0.5 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.0 | 0.6 | GO:0035338 | long-chain fatty-acyl-CoA biosynthetic process(GO:0035338) |
0.0 | 0.4 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.0 | 0.5 | GO:0030517 | negative regulation of axon extension(GO:0030517) |
0.0 | 0.3 | GO:0045214 | sarcomere organization(GO:0045214) |
0.0 | 0.1 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
0.0 | 0.3 | GO:0002483 | antigen processing and presentation of endogenous peptide antigen(GO:0002483) antigen processing and presentation of endogenous peptide antigen via MHC class I(GO:0019885) |
0.0 | 0.1 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
0.0 | 0.6 | GO:0003417 | growth plate cartilage development(GO:0003417) |
0.0 | 0.3 | GO:0002021 | response to dietary excess(GO:0002021) |
0.0 | 0.2 | GO:0070131 | positive regulation of mitochondrial translation(GO:0070131) |
0.0 | 0.3 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.0 | 0.7 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.0 | 0.1 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
0.0 | 0.3 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.6 | GO:0098743 | cell aggregation(GO:0098743) |
0.0 | 0.1 | GO:0034380 | high-density lipoprotein particle assembly(GO:0034380) |
0.0 | 0.3 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.0 | 0.3 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 1.3 | GO:0046324 | regulation of glucose import(GO:0046324) |
0.0 | 0.1 | GO:0001555 | oocyte growth(GO:0001555) |
0.0 | 0.4 | GO:0043562 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.0 | 1.6 | GO:0009250 | glycogen biosynthetic process(GO:0005978) glucan biosynthetic process(GO:0009250) |
0.0 | 0.1 | GO:1902527 | positive regulation of protein monoubiquitination(GO:1902527) |
0.0 | 0.6 | GO:0061003 | positive regulation of dendritic spine morphogenesis(GO:0061003) |
0.0 | 0.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
0.0 | 1.3 | GO:0000381 | regulation of alternative mRNA splicing, via spliceosome(GO:0000381) |
0.0 | 0.5 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 1.1 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 0.2 | GO:0097369 | sodium ion import(GO:0097369) sodium ion import across plasma membrane(GO:0098719) sodium ion import into cell(GO:1990118) |
0.0 | 0.0 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
0.0 | 0.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.0 | 0.1 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.0 | 0.3 | GO:0006953 | acute-phase response(GO:0006953) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 0.4 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.1 | GO:0045964 | positive regulation of catecholamine metabolic process(GO:0045915) positive regulation of dopamine metabolic process(GO:0045964) |
0.0 | 0.1 | GO:0032754 | positive regulation of interleukin-5 production(GO:0032754) |
0.0 | 0.0 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.0 | 0.1 | GO:0035694 | negative regulation of mitochondrial membrane potential(GO:0010917) mitochondrial protein catabolic process(GO:0035694) negative regulation of membrane potential(GO:0045837) |
0.0 | 0.2 | GO:0099566 | regulation of postsynaptic cytosolic calcium ion concentration(GO:0099566) |
0.0 | 0.0 | GO:1904781 | positive regulation of protein localization to centrosome(GO:1904781) |
0.0 | 0.4 | GO:0039703 | viral RNA genome replication(GO:0039694) RNA replication(GO:0039703) |
0.0 | 0.1 | GO:0000724 | double-strand break repair via homologous recombination(GO:0000724) recombinational repair(GO:0000725) |
0.0 | 0.1 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.0 | 0.2 | GO:0019264 | glycine biosynthetic process from serine(GO:0019264) |
0.0 | 0.1 | GO:0051967 | negative regulation of synaptic transmission, glutamatergic(GO:0051967) |
0.0 | 0.2 | GO:0018210 | peptidyl-threonine modification(GO:0018210) |
0.0 | 0.9 | GO:0032570 | response to progesterone(GO:0032570) |
0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
0.0 | 0.2 | GO:2000188 | regulation of cholesterol homeostasis(GO:2000188) |
0.0 | 0.1 | GO:0071205 | protein localization to paranode region of axon(GO:0002175) paranodal junction assembly(GO:0030913) protein localization to juxtaparanode region of axon(GO:0071205) |
0.0 | 0.2 | GO:0060065 | uterus development(GO:0060065) |
0.0 | 0.0 | GO:0061436 | regulation of water loss via skin(GO:0033561) establishment of skin barrier(GO:0061436) |
0.0 | 0.3 | GO:0001759 | organ induction(GO:0001759) |
0.0 | 0.5 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.0 | 0.4 | GO:0045744 | negative regulation of G-protein coupled receptor protein signaling pathway(GO:0045744) |
0.0 | 0.1 | GO:0038060 | nitric oxide-cGMP-mediated signaling pathway(GO:0038060) |
0.0 | 0.1 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.0 | 0.2 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.0 | 0.1 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.1 | GO:0015760 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.0 | 0.2 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
0.0 | 0.3 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.0 | 0.1 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.0 | 0.2 | GO:0090208 | positive regulation of triglyceride biosynthetic process(GO:0010867) positive regulation of triglyceride metabolic process(GO:0090208) |
0.0 | 0.1 | GO:0048665 | neuron fate specification(GO:0048665) |
0.0 | 0.1 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) |
0.0 | 1.4 | GO:0098869 | cellular oxidant detoxification(GO:0098869) cellular detoxification(GO:1990748) |
0.0 | 1.7 | GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity(GO:0043433) |
0.0 | 0.1 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 0.1 | GO:0006695 | cholesterol biosynthetic process(GO:0006695) |
0.0 | 0.4 | GO:0032467 | positive regulation of cytokinesis(GO:0032467) |
0.0 | 0.4 | GO:0032786 | positive regulation of DNA-templated transcription, elongation(GO:0032786) |
0.0 | 0.2 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.0 | 0.2 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0034551 | respiratory chain complex III assembly(GO:0017062) mitochondrial respiratory chain complex III assembly(GO:0034551) mitochondrial respiratory chain complex III biogenesis(GO:0097033) |
0.0 | 0.2 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.1 | GO:0007144 | female meiosis I(GO:0007144) |
0.0 | 0.1 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.0 | 0.1 | GO:0052203 | modulation by symbiont of host molecular function(GO:0052055) modulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052203) modulation by host of symbiont catalytic activity(GO:0052422) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.0 | GO:0042737 | drug catabolic process(GO:0042737) |
0.0 | 1.4 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.2 | GO:0003016 | respiratory system process(GO:0003016) |
0.0 | 0.3 | GO:0030220 | platelet formation(GO:0030220) |
0.0 | 0.1 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.0 | 0.5 | GO:0051489 | regulation of filopodium assembly(GO:0051489) |
0.0 | 0.3 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
0.0 | 0.1 | GO:2001046 | positive regulation of integrin-mediated signaling pathway(GO:2001046) |
0.0 | 0.0 | GO:0016260 | selenocysteine biosynthetic process(GO:0016260) |
0.0 | 0.1 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
0.0 | 0.2 | GO:0002475 | antigen processing and presentation via MHC class Ib(GO:0002475) antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.4 | GO:1903959 | regulation of anion transmembrane transport(GO:1903959) |
0.0 | 0.1 | GO:0006108 | malate metabolic process(GO:0006108) |
0.0 | 0.2 | GO:0042403 | thyroid hormone metabolic process(GO:0042403) |
0.0 | 0.7 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 1.6 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.1 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.0 | 0.1 | GO:0043951 | negative regulation of cAMP-mediated signaling(GO:0043951) |
0.0 | 0.2 | GO:0006607 | NLS-bearing protein import into nucleus(GO:0006607) |
0.0 | 0.2 | GO:0043923 | positive regulation by host of viral transcription(GO:0043923) |
0.0 | 0.9 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
0.0 | 0.1 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.1 | GO:1901374 | acetate ester transport(GO:1901374) |
0.0 | 0.3 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) |
0.0 | 0.1 | GO:0001514 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 2.8 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.2 | 12.8 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.2 | 8.6 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.1 | 6.8 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.1 | 9.5 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.1 | 2.8 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.1 | 5.6 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 10.6 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.1 | 11.9 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.1 | 1.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 3.3 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.1 | 5.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.1 | 0.3 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.1 | 4.1 | NABA COLLAGENS | Genes encoding collagen proteins |
0.1 | 7.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.1 | 4.1 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 0.7 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
0.1 | 17.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 2.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.1 | 0.8 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.1 | 1.7 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 3.0 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
0.1 | 2.5 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 1.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.1 | 0.8 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.0 | 1.5 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 1.2 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 3.0 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.0 | 0.6 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.0 | 2.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 1.3 | PID PDGFRB PATHWAY | PDGFR-beta signaling pathway |
0.0 | 0.9 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 0.4 | PID IL12 2PATHWAY | IL12-mediated signaling events |
0.0 | 2.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.0 | 0.7 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.0 | 1.3 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 0.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.0 | 0.3 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.0 | 0.6 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.2 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
0.0 | 1.5 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.0 | 3.4 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.0 | 0.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.0 | 0.4 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.8 | PID BMP PATHWAY | BMP receptor signaling |
0.0 | 1.0 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.0 | 3.3 | NABA CORE MATRISOME | Ensemble of genes encoding core extracellular matrix including ECM glycoproteins, collagens and proteoglycans |
0.0 | 0.5 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.0 | 0.1 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.0 | 11.9 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
2.1 | 30.8 | GO:0030478 | actin cap(GO:0030478) |
1.6 | 9.4 | GO:0070369 | beta-catenin-TCF7L2 complex(GO:0070369) |
1.0 | 3.0 | GO:0019034 | viral replication complex(GO:0019034) |
0.9 | 3.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.8 | 18.8 | GO:0042627 | chylomicron(GO:0042627) |
0.6 | 1.9 | GO:1902636 | kinociliary basal body(GO:1902636) |
0.6 | 3.1 | GO:0071148 | TEAD-1-YAP complex(GO:0071148) |
0.6 | 2.5 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.6 | 7.7 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.5 | 3.2 | GO:0032311 | angiogenin-PRI complex(GO:0032311) |
0.5 | 1.6 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.5 | 1.8 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.4 | 1.5 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.4 | 4.9 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.4 | 1.5 | GO:0031673 | H zone(GO:0031673) |
0.4 | 2.5 | GO:0098575 | lumenal side of lysosomal membrane(GO:0098575) |
0.3 | 5.3 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 0.6 | GO:0014802 | terminal cisterna(GO:0014802) |
0.3 | 1.3 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.3 | 1.3 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.3 | 2.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.2 | 2.2 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
0.2 | 1.9 | GO:0070022 | transforming growth factor beta receptor homodimeric complex(GO:0070022) |
0.2 | 1.9 | GO:0005579 | membrane attack complex(GO:0005579) |
0.2 | 1.5 | GO:0016589 | NURF complex(GO:0016589) |
0.2 | 4.1 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
0.2 | 3.7 | GO:0032433 | filopodium tip(GO:0032433) |
0.2 | 3.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.2 | 2.3 | GO:0005916 | fascia adherens(GO:0005916) |
0.2 | 1.4 | GO:0045179 | apical cortex(GO:0045179) |
0.2 | 1.8 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.1 | 0.7 | GO:0060201 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.1 | 0.4 | GO:0097454 | Schwann cell microvillus(GO:0097454) |
0.1 | 1.3 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.1 | 1.4 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.1 | 2.7 | GO:0000145 | exocyst(GO:0000145) |
0.1 | 0.9 | GO:0005902 | microvillus(GO:0005902) |
0.1 | 1.0 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.1 | 11.7 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.3 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
0.1 | 1.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.3 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.1 | 0.3 | GO:0090498 | extrinsic component of Golgi membrane(GO:0090498) |
0.1 | 0.7 | GO:0001939 | female pronucleus(GO:0001939) |
0.1 | 1.2 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.1 | 0.3 | GO:0042765 | GPI-anchor transamidase complex(GO:0042765) |
0.1 | 0.3 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
0.1 | 3.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.1 | 0.3 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.1 | 0.1 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.1 | 0.2 | GO:0000974 | Prp19 complex(GO:0000974) |
0.1 | 1.5 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.1 | 1.0 | GO:0097470 | ribbon synapse(GO:0097470) |
0.1 | 2.6 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.1 | 0.3 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 12.2 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.1 | 0.9 | GO:0044300 | cerebellar mossy fiber(GO:0044300) |
0.1 | 2.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.1 | 14.5 | GO:0031674 | I band(GO:0031674) |
0.1 | 7.7 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.6 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) |
0.1 | 0.9 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.5 | GO:0033270 | paranode region of axon(GO:0033270) |
0.1 | 1.0 | GO:0008091 | spectrin(GO:0008091) |
0.1 | 0.2 | GO:1990812 | growth cone filopodium(GO:1990812) |
0.1 | 6.5 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.1 | 0.8 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 0.3 | GO:0031302 | intrinsic component of endosome membrane(GO:0031302) |
0.1 | 2.9 | GO:0044291 | cell-cell contact zone(GO:0044291) |
0.1 | 0.3 | GO:0071546 | perinucleolar chromocenter(GO:0010370) pi-body(GO:0071546) |
0.1 | 17.8 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.1 | 0.4 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.1 | 1.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 1.1 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.1 | 0.4 | GO:1990037 | Lewy body core(GO:1990037) |
0.1 | 1.4 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.1 | 0.2 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.1 | 1.2 | GO:0097546 | ciliary base(GO:0097546) |
0.1 | 0.5 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.1 | 0.2 | GO:0097440 | apical dendrite(GO:0097440) |
0.0 | 1.3 | GO:0005770 | late endosome(GO:0005770) |
0.0 | 0.2 | GO:0032044 | DSIF complex(GO:0032044) |
0.0 | 0.2 | GO:0061700 | GATOR2 complex(GO:0061700) |
0.0 | 0.7 | GO:0001741 | XY body(GO:0001741) |
0.0 | 0.9 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 2.6 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.0 | 0.1 | GO:0031251 | PAN complex(GO:0031251) |
0.0 | 0.3 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.0 | 0.2 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.7 | GO:0071141 | SMAD protein complex(GO:0071141) |
0.0 | 1.1 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 0.2 | GO:0045272 | plasma membrane respiratory chain complex I(GO:0045272) |
0.0 | 0.5 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.6 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.4 | GO:0031209 | SCAR complex(GO:0031209) |
0.0 | 0.4 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.0 | 0.1 | GO:0034657 | GID complex(GO:0034657) |
0.0 | 0.2 | GO:0030128 | clathrin coat of endocytic vesicle(GO:0030128) |
0.0 | 0.3 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.2 | GO:0044308 | axonal spine(GO:0044308) |
0.0 | 0.3 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.0 | 0.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 0.5 | GO:0001527 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 1.7 | GO:0016459 | myosin complex(GO:0016459) |
0.0 | 0.6 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.0 | 0.6 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 1.4 | GO:0005844 | polysome(GO:0005844) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 1.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 1.2 | GO:0043198 | dendritic shaft(GO:0043198) |
0.0 | 0.1 | GO:0005712 | chiasma(GO:0005712) |
0.0 | 1.6 | GO:0097610 | cleavage furrow(GO:0032154) cell surface furrow(GO:0097610) |
0.0 | 0.4 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
0.0 | 0.2 | GO:0044232 | organelle membrane contact site(GO:0044232) |
0.0 | 0.2 | GO:0016011 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.0 | 0.5 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.0 | 0.1 | GO:0000333 | telomerase catalytic core complex(GO:0000333) |
0.0 | 0.1 | GO:0001652 | granular component(GO:0001652) |
0.0 | 4.1 | GO:0030055 | cell-substrate adherens junction(GO:0005924) focal adhesion(GO:0005925) cell-substrate junction(GO:0030055) |
0.0 | 0.4 | GO:0097225 | sperm midpiece(GO:0097225) |
0.0 | 0.8 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.6 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.5 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:1990622 | CHOP-ATF3 complex(GO:1990622) |
0.0 | 0.7 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.7 | GO:0036064 | ciliary basal body(GO:0036064) |
0.0 | 0.8 | GO:0000922 | spindle pole(GO:0000922) |
0.0 | 0.2 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.3 | GO:0005798 | Golgi-associated vesicle(GO:0005798) |
0.0 | 0.8 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 1.2 | GO:0005881 | cytoplasmic microtubule(GO:0005881) |
0.0 | 0.1 | GO:0070069 | mitochondrial respiratory chain complex IV(GO:0005751) respiratory chain complex IV(GO:0045277) cytochrome complex(GO:0070069) |
0.0 | 0.8 | GO:0005791 | rough endoplasmic reticulum(GO:0005791) |
0.0 | 1.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.0 | 0.4 | GO:0031252 | cell leading edge(GO:0031252) |
0.0 | 2.8 | GO:0031901 | early endosome membrane(GO:0031901) |
0.0 | 0.2 | GO:0070552 | BRISC complex(GO:0070552) |
0.0 | 1.8 | GO:0030658 | transport vesicle membrane(GO:0030658) |
0.0 | 1.0 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.0 | 1.7 | GO:0035578 | azurophil granule lumen(GO:0035578) |
0.0 | 0.7 | GO:0005771 | multivesicular body(GO:0005771) |
0.0 | 1.0 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 1.0 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 2.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.0 | 0.4 | GO:0031594 | neuromuscular junction(GO:0031594) |
0.0 | 0.3 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.0 | 0.2 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.0 | 0.1 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.3 | GO:0031941 | filamentous actin(GO:0031941) |
0.0 | 0.4 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.0 | 0.0 | GO:0072534 | perineuronal net(GO:0072534) |
0.0 | 0.4 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.0 | 1.3 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.3 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 0.1 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.0 | 0.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.0 | 0.1 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) NatA complex(GO:0031415) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0098858 | actin-based cell projection(GO:0098858) |
0.0 | 0.2 | GO:0016580 | Sin3 complex(GO:0016580) |
0.0 | 0.3 | GO:0008021 | synaptic vesicle(GO:0008021) |
0.0 | 0.1 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 0.1 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.0 | 0.3 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.0 | 0.4 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 1.9 | GO:0005764 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 7.0 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) |
0.0 | 6.2 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.0 | 4.1 | GO:0005774 | vacuolar membrane(GO:0005774) |
0.0 | 1.9 | GO:0031965 | nuclear membrane(GO:0031965) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 23.8 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
0.6 | 15.4 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.6 | 35.9 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 11.2 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 8.8 | REACTOME CHYLOMICRON MEDIATED LIPID TRANSPORT | Genes involved in Chylomicron-mediated lipid transport |
0.3 | 4.1 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.3 | 4.2 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.2 | 0.8 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.2 | 4.8 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.2 | 0.4 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.2 | 5.4 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.2 | 4.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.2 | 0.3 | REACTOME FORMATION OF THE HIV1 EARLY ELONGATION COMPLEX | Genes involved in Formation of the HIV-1 Early Elongation Complex |
0.1 | 2.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 2.2 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.1 | 3.1 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.3 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.1 | 3.3 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.1 | 2.2 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.1 | 2.1 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 1.9 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 3.0 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.5 | REACTOME ACTIVATION OF CHAPERONES BY ATF6 ALPHA | Genes involved in Activation of Chaperones by ATF6-alpha |
0.1 | 2.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 2.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.1 | 1.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.1 | 3.5 | REACTOME IRON UPTAKE AND TRANSPORT | Genes involved in Iron uptake and transport |
0.1 | 0.1 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.1 | 2.4 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.3 | REACTOME SIGNALING BY EGFR IN CANCER | Genes involved in Signaling by EGFR in Cancer |
0.1 | 2.2 | REACTOME REGULATION OF GENE EXPRESSION IN BETA CELLS | Genes involved in Regulation of gene expression in beta cells |
0.1 | 1.4 | REACTOME HS GAG BIOSYNTHESIS | Genes involved in HS-GAG biosynthesis |
0.1 | 4.1 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.1 | 2.6 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.1 | 2.2 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.1 | 0.9 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.1 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.1 | 3.2 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.1 | 1.0 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 1.1 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.0 | 0.6 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.0 | 0.9 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.0 | 0.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.9 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
0.0 | 0.9 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.0 | 7.0 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.0 | 0.3 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.0 | 0.4 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 9.2 | REACTOME MRNA PROCESSING | Genes involved in mRNA Processing |
0.0 | 1.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 2.0 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.0 | 0.6 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.0 | 0.6 | REACTOME NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Norepinephrine Neurotransmitter Release Cycle |
0.0 | 1.1 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.8 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.2 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.9 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.9 | REACTOME DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY | Genes involved in Downregulation of SMAD2/3:SMAD4 transcriptional activity |
0.0 | 0.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.0 | 1.3 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.5 | REACTOME CRMPS IN SEMA3A SIGNALING | Genes involved in CRMPs in Sema3A signaling |
0.0 | 0.8 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.0 | 0.6 | REACTOME SIGNALING BY NOTCH | Genes involved in Signaling by NOTCH |
0.0 | 2.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.0 | 0.1 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.0 | 0.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.1 | REACTOME SIGNALING BY WNT | Genes involved in Signaling by Wnt |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.3 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 1.5 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.0 | 0.7 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 1.1 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.1 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.2 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.0 | 0.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.0 | 0.2 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 1.3 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.2 | REACTOME CYTOSOLIC SULFONATION OF SMALL MOLECULES | Genes involved in Cytosolic sulfonation of small molecules |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.4 | 7.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
2.2 | 10.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
2.0 | 8.0 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
1.7 | 13.9 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
1.7 | 5.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
1.0 | 27.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.8 | 2.4 | GO:0046573 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
0.8 | 12.3 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.8 | 3.8 | GO:0090554 | phosphatidylcholine-translocating ATPase activity(GO:0090554) |
0.7 | 2.1 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.7 | 12.6 | GO:0045295 | gamma-catenin binding(GO:0045295) |
0.6 | 2.5 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.6 | 3.1 | GO:0034046 | poly(G) binding(GO:0034046) |
0.6 | 2.3 | GO:0016841 | ammonia-lyase activity(GO:0016841) |
0.5 | 1.6 | GO:0015091 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.5 | 3.8 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.5 | 3.1 | GO:0004522 | ribonuclease A activity(GO:0004522) |
0.5 | 1.5 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.5 | 1.9 | GO:0008184 | purine nucleobase binding(GO:0002060) glycogen phosphorylase activity(GO:0008184) |
0.4 | 1.3 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.4 | 2.5 | GO:0035800 | deubiquitinase activator activity(GO:0035800) |
0.4 | 1.2 | GO:0010698 | acetyltransferase activator activity(GO:0010698) |
0.4 | 3.7 | GO:0060002 | plus-end directed microfilament motor activity(GO:0060002) |
0.4 | 1.6 | GO:0019862 | IgA binding(GO:0019862) |
0.4 | 1.2 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.4 | 1.9 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.4 | 1.9 | GO:0002046 | opsin binding(GO:0002046) |
0.4 | 1.5 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.4 | 2.6 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.4 | 1.4 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.4 | 2.9 | GO:0019871 | sodium channel inhibitor activity(GO:0019871) |
0.4 | 6.4 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.4 | 1.4 | GO:0047708 | biotinidase activity(GO:0047708) |
0.3 | 1.0 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.3 | 1.3 | GO:0004598 | peptidylglycine monooxygenase activity(GO:0004504) peptidylamidoglycolate lyase activity(GO:0004598) |
0.3 | 1.3 | GO:0060422 | peptidyl-dipeptidase inhibitor activity(GO:0060422) |
0.3 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.3 | 4.6 | GO:0015643 | toxic substance binding(GO:0015643) |
0.3 | 0.9 | GO:0052810 | 1-phosphatidylinositol-5-kinase activity(GO:0052810) |
0.3 | 1.4 | GO:0010465 | nerve growth factor receptor activity(GO:0010465) |
0.3 | 0.8 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.3 | 1.3 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) |
0.3 | 0.3 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.3 | 2.5 | GO:0045159 | myosin II binding(GO:0045159) |
0.2 | 1.4 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.2 | 1.8 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 0.6 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
0.2 | 1.0 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.2 | 0.8 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 1.8 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
0.2 | 0.2 | GO:0003990 | acetylcholinesterase activity(GO:0003990) |
0.2 | 2.4 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.2 | 0.6 | GO:0004088 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.2 | 1.4 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.2 | 0.6 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.2 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.2 | 1.7 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.2 | 19.9 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.2 | 2.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
0.2 | 1.1 | GO:0060698 | endoribonuclease inhibitor activity(GO:0060698) |
0.2 | 0.8 | GO:0005294 | neutral L-amino acid secondary active transmembrane transporter activity(GO:0005294) |
0.2 | 5.2 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.2 | 1.1 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.2 | 0.8 | GO:0016402 | pristanoyl-CoA oxidase activity(GO:0016402) |
0.2 | 4.4 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.2 | 0.3 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) |
0.2 | 0.6 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.2 | 0.5 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.2 | 2.5 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
0.2 | 2.1 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.2 | 0.5 | GO:0030366 | molybdopterin synthase activity(GO:0030366) |
0.1 | 0.7 | GO:0030348 | syntaxin-3 binding(GO:0030348) |
0.1 | 1.0 | GO:0016618 | hydroxypyruvate reductase activity(GO:0016618) glyoxylate reductase (NADP) activity(GO:0030267) |
0.1 | 1.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 2.9 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 1.5 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 1.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0008523 | sodium-dependent multivitamin transmembrane transporter activity(GO:0008523) |
0.1 | 0.7 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 0.7 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
0.1 | 0.8 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.1 | 1.1 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.1 | 4.5 | GO:0015020 | glucuronosyltransferase activity(GO:0015020) |
0.1 | 0.4 | GO:0035500 | MH2 domain binding(GO:0035500) |
0.1 | 1.4 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 9.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.1 | 1.5 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.1 | 1.1 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
0.1 | 2.5 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.1 | 0.4 | GO:0052870 | tocopherol omega-hydroxylase activity(GO:0052870) alpha-tocopherol omega-hydroxylase activity(GO:0052871) 20-hydroxy-leukotriene B4 omega oxidase activity(GO:0097258) 20-aldehyde-leukotriene B4 20-monooxygenase activity(GO:0097259) |
0.1 | 0.4 | GO:0050698 | proteoglycan sulfotransferase activity(GO:0050698) |
0.1 | 0.7 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.1 | 3.0 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 1.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.1 | 3.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.1 | 1.9 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.3 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
0.1 | 0.5 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 11.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 1.0 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
0.1 | 0.3 | GO:0003923 | GPI-anchor transamidase activity(GO:0003923) |
0.1 | 0.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.1 | 0.2 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
0.1 | 8.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.6 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
0.1 | 1.3 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.1 | 0.4 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.1 | 0.3 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.1 | 0.3 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 4.7 | GO:0001105 | RNA polymerase II transcription coactivator activity(GO:0001105) |
0.1 | 0.3 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.1 | 0.3 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.3 | GO:0004139 | deoxyribose-phosphate aldolase activity(GO:0004139) |
0.1 | 0.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.1 | 0.6 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.1 | 0.5 | GO:0086080 | protein binding involved in heterotypic cell-cell adhesion(GO:0086080) |
0.1 | 0.6 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
0.1 | 0.9 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.1 | 1.3 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.5 | GO:0035374 | chondroitin sulfate binding(GO:0035374) |
0.1 | 6.0 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.1 | 1.7 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 1.6 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.1 | 1.4 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.1 | 0.4 | GO:1903135 | cupric ion binding(GO:1903135) |
0.1 | 0.4 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) 3alpha,7alpha,12alpha-trihydroxy-5beta-cholest-24-enoyl-CoA hydratase activity(GO:0033989) 17-beta-hydroxysteroid dehydrogenase (NAD+) activity(GO:0044594) |
0.1 | 2.3 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.1 | 0.1 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.1 | 10.9 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 6.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 0.4 | GO:0043426 | MRF binding(GO:0043426) |
0.1 | 0.5 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.1 | 0.5 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.1 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.3 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 1.1 | GO:0008569 | ATP-dependent microtubule motor activity, minus-end-directed(GO:0008569) |
0.1 | 0.2 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
0.1 | 0.2 | GO:1901474 | thiamine transmembrane transporter activity(GO:0015234) thiamine uptake transmembrane transporter activity(GO:0015403) azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.4 | GO:0003998 | acylphosphatase activity(GO:0003998) |
0.1 | 10.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.1 | 0.2 | GO:0061752 | telomeric repeat-containing RNA binding(GO:0061752) |
0.1 | 0.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 0.8 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.1 | 0.2 | GO:0031691 | alpha-1A adrenergic receptor binding(GO:0031691) follicle-stimulating hormone receptor binding(GO:0031762) platelet activating factor receptor binding(GO:0031859) |
0.1 | 0.9 | GO:0005391 | sodium:potassium-exchanging ATPase activity(GO:0005391) |
0.1 | 0.3 | GO:0009922 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 1.1 | GO:0005537 | mannose binding(GO:0005537) |
0.1 | 0.7 | GO:0035497 | cAMP response element binding(GO:0035497) |
0.1 | 1.8 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 0.2 | GO:0004947 | bradykinin receptor activity(GO:0004947) |
0.1 | 0.4 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 2.7 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 0.2 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 0.8 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 0.3 | GO:0017050 | sphinganine kinase activity(GO:0008481) D-erythro-sphingosine kinase activity(GO:0017050) |
0.1 | 0.7 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.5 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 1.4 | GO:0042056 | chemoattractant activity(GO:0042056) |
0.1 | 0.6 | GO:0015379 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.2 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.0 | 0.1 | GO:0050429 | calcium-dependent phospholipase C activity(GO:0050429) |
0.0 | 1.4 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.0 | 0.9 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 2.1 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 3.0 | GO:0030971 | receptor tyrosine kinase binding(GO:0030971) |
0.0 | 0.6 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.0 | 0.7 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.0 | 0.4 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.3 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 1.0 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.0 | 0.6 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 1.3 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
0.0 | 0.3 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.0 | 0.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 4.6 | GO:0008201 | heparin binding(GO:0008201) |
0.0 | 1.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 1.3 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.2 | GO:0004793 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
0.0 | 1.0 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.0 | 2.4 | GO:0097110 | scaffold protein binding(GO:0097110) |
0.0 | 0.2 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.5 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.1 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.0 | 0.1 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
0.0 | 1.4 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
0.0 | 3.2 | GO:0004866 | endopeptidase inhibitor activity(GO:0004866) |
0.0 | 1.3 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.1 | GO:0050528 | acyloxyacyl hydrolase activity(GO:0050528) |
0.0 | 0.8 | GO:0042171 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
0.0 | 0.1 | GO:0080130 | L-phenylalanine aminotransferase activity(GO:0070546) L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.0 | 0.3 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.0 | 2.5 | GO:0030165 | PDZ domain binding(GO:0030165) |
0.0 | 0.4 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.1 | GO:0017018 | myosin phosphatase activity(GO:0017018) |
0.0 | 0.7 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) transmembrane receptor protein phosphatase activity(GO:0019198) |
0.0 | 0.6 | GO:0102391 | decanoate--CoA ligase activity(GO:0102391) |
0.0 | 0.3 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.6 | GO:0000339 | RNA cap binding(GO:0000339) |
0.0 | 0.4 | GO:0034450 | ubiquitin-ubiquitin ligase activity(GO:0034450) |
0.0 | 0.2 | GO:0004118 | cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) |
0.0 | 1.2 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.0 | 0.8 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.0 | 0.1 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.0 | 0.2 | GO:0015386 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.0 | 0.2 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.0 | 0.8 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.2 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.0 | 0.4 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 0.5 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 1.5 | GO:0004004 | ATP-dependent RNA helicase activity(GO:0004004) |
0.0 | 0.1 | GO:0017040 | ceramidase activity(GO:0017040) |
0.0 | 0.3 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.0 | 0.0 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.1 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
0.0 | 0.1 | GO:0016434 | rRNA (cytosine) methyltransferase activity(GO:0016434) |
0.0 | 1.2 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.0 | 0.6 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.2 | GO:0030274 | LIM domain binding(GO:0030274) |
0.0 | 0.4 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.0 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
0.0 | 0.1 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.2 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.6 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0038191 | neuropilin binding(GO:0038191) |
0.0 | 1.3 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.1 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.0 | 0.5 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 0.1 | GO:0035368 | selenocysteine insertion sequence binding(GO:0035368) |
0.0 | 0.1 | GO:0051377 | mannose-ethanolamine phosphotransferase activity(GO:0051377) |
0.0 | 0.2 | GO:0031702 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.4 | GO:0004629 | phosphatidylinositol phospholipase C activity(GO:0004435) phospholipase C activity(GO:0004629) |
0.0 | 2.2 | GO:0044325 | ion channel binding(GO:0044325) |
0.0 | 0.6 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.0 | 0.1 | GO:0008513 | secondary active organic cation transmembrane transporter activity(GO:0008513) |
0.0 | 2.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.0 | 0.1 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.1 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.0 | 0.2 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.0 | 0.4 | GO:0005521 | lamin binding(GO:0005521) |
0.0 | 0.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
0.0 | 0.1 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.0 | 0.1 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 0.1 | GO:0043022 | ribosome binding(GO:0043022) |
0.0 | 0.0 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
0.0 | 0.1 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) phosphatidylinositol-4,5-bisphosphate 4-phosphatase activity(GO:0034597) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.0 | 0.4 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0005112 | Notch binding(GO:0005112) |
0.0 | 0.0 | GO:0051120 | hepoxilin A3 synthase activity(GO:0051120) |
0.0 | 0.5 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.9 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0003696 | satellite DNA binding(GO:0003696) |
0.0 | 0.1 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.0 | 0.2 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.0 | 0.2 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.4 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.1 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.0 | 0.1 | GO:0032454 | histone demethylase activity (H3-K9 specific)(GO:0032454) |
0.0 | 0.1 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.0 | 0.1 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.3 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.2 | GO:0019843 | rRNA binding(GO:0019843) |
0.0 | 0.1 | GO:0015101 | organic cation transmembrane transporter activity(GO:0015101) |
0.0 | 0.0 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
0.0 | 0.3 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
0.0 | 0.3 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |